1. Introduction
The human corneal stroma contains human corneal stromal cells (hCSCs). The term hCSCs is used for both corneal keratocytes and corneal fibroblasts. hCSCs in a healthy cornea are represented by mitotically resting immobile keratocytes. They perform the function of producing and maintaining the extracellular matrix, ensuring morphostructural and biochemical stability, and the transparency of the corneal tissue [
1,
2]. Keratocytes can transform into fibroblasts and myofibroblasts under the influence of TGF-β, IL-1 when thecornea is damaged. Corneal fibroblasts (CFs) are activated keratocytes, of which the pronounced proliferative activity is essential for rapid cell expansion. CFs act as signal cells by attracting inflammatory cells. They are involved in the restoration of the cornea, producing collagen, elastin, proteoglycans, and glycoproteins. The activation of keratocytes in fibroblasts is also observed in vitro when cultured in a medium supplemented with serum [
3]. After the repair of corneal damage (in the absence of TGF-β, IL-1) or when cultured in a serum-free keratocyte growth medium (KGM) supplemented with ascorbic acid, ITS and bFGF, CFs can be reversed into resting keratocytes [
4,
5]. CFs can transform into myofibroblasts through an excessive stimulation of TGF-β. Myofibroblasts are involved in corneal regeneration by causing wound contraction, fibrous extracellular matrix organization, and scar formation [
6,
7]. They are terminated when the tissues are repaired by apoptosis or deactivated [
6].
Fibrosis of the stroma during its damage (burn, traumatic, after surgical interventions) leads to blindness [
8]. In addition, the pathogenesis of many ectatic conditions, as well as genetically determined anomalies and congenital dystrophies of the cornea, is associated with increased apoptosis and a loss of keratocytes [
9]. Corneal blindness is the third leading cause of low vision after cataracts and glaucoma [
10]. About 12.7 million people in the world are in need of donor cornea transplantation [
11]. Due to the shortage of donor corneas, new approaches to the treatment of corneal blindness are being sought. Such approaches are cell therapy and the development of tissue-engineered corneal constructs, which are an alternative to corneal allotransplantation. The development of these approaches is associated with the availability of corneal stroma cells, i.e., keratocytes. The quality of the restoration of the cornea is determined by the phenotype of keratocytes in the transplant.
Earlier studies have shown that human cornea can be used as a source of hCSCs. For these purposes, a primary keratocyte culture is obtained from the cornea by peeling the epithelium and removing the corneal endothelium [
12,
13]. However, due to the shortage of donor corneas, hCSCs are usually isolated from the corneoscleral rings of the peripheral cornea removed during keratoplasty. Since keratocytes in the corneal stroma are distributed unevenly, about 10% of vimentin-positive keratocytes are located in the areas of Bowman’s and Descemet’s membranes, so some researchers consider it a necessary condition for an effective differentiation of keratocytes into fibroblasts and myofibroblasts in case of corneal damage [
14]. The density of stromal cells decreases from the anterior to the posterior sections of stroma cornea [
15]. In this regard, it would be advantageous to use the anterior–central corneal part as a source of primary hCSC culture.
Small incision lenticule extraction (ReLEx SMILE) is widely used to correct myopia and myopic astigmatism [
16]. The decellularized corneal stromal equivalents obtained from the ReLEx SMILE lenticules are a novel and accessible source of biocompatibility collagen-rich extracellular matrix scaffolds for regenerative medicine [
17]. ReLEx SMILE lenticules are a safe and effective alternative for treating corneal ulcers and perforations in animals [
18] and humans [
19]. Keratoplasty using SMILE lenticules is often performed for treatment of post-LASIK corneal ectasia [
20], presbyopia [
21], and in surgical treatment of keratoconus [
22]. There are also two publications describing the CFs isolated from lenticules [
23,
24].
In recent years, the number of surgical corrections of myopia and astigmatism using ReLEx SMILE has significantly increased. Since most patients to have undergone ReLEx SMILE are conditionally healthy young people, many healthy corneal lenticules are obtained after the correction. Considering the deficiency of corneas, especially their anterior–central part, we propose using fresh lenticules as a source of hCSCs in vitro. The method is especially advantageous for lenticules, since it does not require removing the epithelial and endothelial cells from the outer and inner surfaces. Therefore, corneal stromal lenticules become an accessible source for isolating a ‘pure’ culture of corneal stromal cells.
The aim of this study was to derive keratocytes through the reversal of corneal fibroblasts from ReLEx SMILE lenticules, and study the morphofunctional changes accompanying the reversion of fibroblasts to keratocytes.
3. Discussion
Corneal keratocytes are quiescent cells, so it is difficult to expand them in vitro at a significant level for cell therapy and tissue engineering. This problem could be overcome by expanding CFs with high proliferative potential and their reversion into the keratocytes that maintain the morphofunctional properties of primary keratocytes. We have previously shown that ReLEx SMILE lenticules can be used to isolate the primary cultures of corneal fibroblasts [
25]. In the present study, it has been demonstrated that fibroblasts from ReLEx SMILE lenticules reverse into keratocytes in serum-free KGM, maintaining the morphology and functional properties of primary keratocytes.
Previous studies demonstrated that CFs had the plasticity to differentiate into keratocytes [
26,
27]. This phenomenon was confirmed in our study where the CFs in KGM become similar to keratocytes. Here, we showed that fibroblast reversion was accompanied by a change in cell morphology. The rCFs acquired a dendritic shape and formed long cytoplasmic processes. They formed patterns shaped as waves and arcs (
Figure 1B). The actin cytoskeleton stained with phalloidin demonstrated a sparse network of F-actin fibers, with a predominantly cortical actin organization (
Figure 1D).
According to the TEM data, rCFs were more functionally active than CFs. This is confirmed by the high electron density of the cytoplasm, as well as a higher content of membranes of the rough endoplasmic reticulum and Golgi complex, and large activated nucleoli in the nucleus. The presence of large activated nucleoli in the rCF nucleus is a structural sign of the activation of synthetic processes. We suggest that fibroblast reversion leads to the activation of protein synthesis, in particular, keratocan, lumican, and extracellular matrix proteins. It is likely that the high mitochondrial content leads to an increase in rCF metabolism (
Figure 2A,B). After reversion, rCFs had immunophenotypic signs of keratocytes. They expressed keratocyte markers such as keratocan, lumican, and ALDH1A1, and no markers of mesenchymal stem cells (CD90, CD73, and CD105) and adhesive molecules (
Figure 3A,C).
Thus, cultivation in KGM reverts corneal fibroblasts into keratocytes and restores keratocyte markers (keratocan, lumican), except for CD34, being a marker of remaining keratocytes in vivo [
28]. The role of CD34 expression in keratocytes has not been elucidated yet, but it is assumed that it is involved in the regulation of adhesion, differentiation, and quiescent states [
28,
29]. However, it has been shown that keratocytes express CD34 only in corneal stroma, and lose this marker in isolation [
30].
It was previously reported that the cultivation of corneal fibroblasts in a medium with 10% FCS can result in their differentiation into myofibroblasts. [
31]. Myofibroblasts are involved in corneal regeneration by causing wound contraction, fibrous extracellular matrix organization, and scar formation. These cells are characterized by a larger size compared to CFs, and a high level of α-SMA expression. The possibility of reversion of corneal myofibroblasts to fibroblasts and then to keratocytes, remains a controversial issue [
32]. In our study, no changes were found in the morphology of corneal cells during their cultivation in a 10% FCS medium and no α-SMA expression in CF 3–6 passage was observed (
Figure 3C). Therefore, the primary cells derived from lenticules in a medium containing 10% FCS were fibroblasts. This result agrees with the data of [
27,
33].
Fundebug et al. demonstrated that the primary keratocytes isolated from the corneal stroma caused a spontaneous formation of spheroids [
34]. A similar phenomenon was observed in our study with rCFs. The spheroids increased in size by the eleventh day of cultivation, and the cells in the spheroids remained alive (
Figure 4). The formation of spheroids is the indirect evidence that the keratocytes obtained from the fibroblast reversion acquire not only morphological, but also functional properties of primary corneal keratocytes.
Because keratocytes have low functional activity (do not proliferate or migrate in a healthy cornea), we investigated the functional activity of the rCFs in the presence of a mitogen (2% and 10% FCS). It was found that 10% FCS led to a significant increase in the CI proliferation of rCFs compared to the depleted medium (2% FCS) and control (0% FCS) (
Figure 5). Thus, FCS is a powerful mitogenic stimulus to accelerate the proliferation of rCF. It should be noted that during the first four hours of the experiment, rCF CIs were comparable at 0%, 2%, and 10% FCS, probably due to cell adhesion. A slight activation of rCFs can be caused by a 0.25% trypsin/0.02% EDTA solution during the detachment of the adherent cells. Unlike corneal fibroblasts, rCFs after adhesion and spreading in a serum-free medium became dormant and do not proliferate until the end of the experiment. At the end of the experiment (after 120 h), fluorescent staining with acridine orange and propidium iodide was performed to show that the low proliferative activity of rCF was not associated with their apoptosis or death.
Figure 5D shows that the rCFs were live (stained green with acridine orange).
We found that rCFs have low migratory activity compared to corneal fibroblasts (
Figure 6). The growth factor concentration in FCS had a lesser effect on cell migration activity than on their proliferation. The rCF migration was weak even with the addition of 10% FCS. Thus, the reversion of fibroblasts into keratocytes is accompanied not only by changes in cell morphology, but also by changes in their functional activity (proliferation and migration). The low rCF proliferative and migratory potentials were similar to those of primary keratocytes.
The main function of primary keratocytes is associated with the synthesis and degradation of the extracellular matrix of the cornea. Therefore, it is important that rCFs support the synthesis of the extracellular matrix components. Healthy corneal keratocytes are characterized by a low expression of corneal extracellular matrix components (fibronectin and collagen) in contrast to CFs, and especially myofibroblasts [
35,
36]. Fibronectin and collagen play a key role in CF migration [
36,
37].
Figure 3C shows that rCFs expressed less fibronectin than CFs. We have previously shown that the production of fibronectin and total collagen by rCFs is comparable to that of CFs. Similarity in the production of fibronectin and collagen by rCFs is probably due to the initially low level of their production by CFs [
25].
The cytokines and growth factors produced by cells in the cornea are involved in regulating chemotaxis, cell proliferation, migration, inflammation, normal angiogenesis, and wound healing [
34]. We studied the effect of fibroblast reversion into keratocytes on the production of cytokines and growth factors. The protein components studied included VEGF, IGF-1, TNF-α, sICAM-1, and SDF-1a (
Figure 7). These protein components maintain corneal homeostasis and are involved in inflammation. The analysis of biologically active substances in the culture medium showed that the rCFs produced less VEGF (
p = 0.031) (
Figure 7). VEGF production by many cells, including CFs, was shown in [
38]. Philipp et al. demonstrated that, unlike activated fibroblasts, corneal stromal keratocytes weakly express VEGF [
39]. The normal cornea is avascular, which causes its transparency. VEGF causes quiescent cells activation, so they participate in proliferation and migration regulation and form intercellular contacts [
40]. The rCFs in our study did not proliferate and migrate, which can be associated with the low VEGF production in these cells.
We found no effect of the reversion of corneal fibroblasts into keratocytes on the production of IGF-1, TNF-α, sICAM-1, and SDF-1α. IGF-1, a protein of the insulin-like growth factor family, responsible for maintaining corneal homeostasis. This protein regulates the formation of a communication network (formation of a cell network) between keratocytes [
41], proliferation, and differentiation of keratocytes into fibroblasts and myofibroblasts during inflammation and wounding [
42]. Sarenak et al. showed that IGF-1 increases the secretion of keratocan, lumican, and cytosolic ALDH3A1. IGF-1 reduces the likelihood of scarring on the corneal stroma by increasing the proliferation of keratocytes and influencing wound healing [
43]. IGF-1 secretion in corneal fibroblasts was shown by Ko et al. [
44]. At the same time, Berthaut et al. found no IGF-1 expression in CFs [
45]. In our study, we demonstrated IGF-1 production not only by rCFs, but also by fibroblasts.
The pro-inflammatory cytokine TNF-ά, adhesion molecules ICAM-1, and chemokine SDF-1 (stromal cell factor-1) play an important role in the regulation of allergic and inflammatory reactions during infectious and non-infectious processes in the cornea. These molecules ensure the migration of macrophages and leukocytes. They also promote tissue infiltration and the activation of polymorphonuclear neutrophils in the focus of inflammation [
46,
47,
48]. Several cell types, including corneal fibroblasts, express TNF-ά [
46] and SDF-1 [
48]. The expression of the adhesion molecule ICAM-1 was shown on CFs [
47] and keratocytes [
49]. The similarity in the production of IGF-1, TNF-α, sICAM-1, and SDF-1a between rCFs and CFs indicates that the fibroblast reversion is not accompanied by induction of inflammation, and should be attributed to the healthy corneas used as a hCSC source.
Reversion CFs from ReLEx SMILE lenticules into keratocytes has been shown in the present study. The CF reversion into keratocytes was accompanied by changes in cell morphology and the expression of specific keratocyte markers (keratocan and lumican), as well as the loss of specific mesenchymal markers and their proliferative and migratory activities. The reversion of CFs into keratocytes was not accompanied by a change in the production of cytokines, with the exception of VEGF. rCFs were able to form spheres spontaneously. The study has demonstrated that keratocytes, derived through the reversion of fibroblasts from ReLEx SMILE lenticules, can be used for corneal tissue engineering and cell therapy of corneal pathologies.
The development of a new approach for the derivation of corneal stromal cells from the biological material usually disposed looks promising against the backdrop of a shortage of corneas throughout the world. The success of cell therapy depends not only on the choice of the cell source, but also on the microenvironment of the cells after their introduction. Corneal fibroblasts, being regional cells of mesenchymal origin, have the ability to produce extracellular matrix proteins. In addition, they are already committed to the cornea, so they can be more efficiently differentiated into keratocytes. Therefore, it is preferable to use corneal stromal cells for cell therapy and tissue engineering. In our opinion, this will ensure the formation of an adequate microenvironment and modulation of host keratocytes due to the paracrine effect of the cells when injected into the cornea.
4. Materials and Methods
4.1. Ethics Statement
The research involving humans was performed with the prior approval of the Local Ethics Committee of S. Fedorov Eye Microsurgery Federal State Institution (# 1 of 14 January 2021). All procedures were conducted in accordance with the principles and guidelines of the Declaration of Helsinki. Informed consent was obtained from all 30 myopic patients enrolled in this study in January–May 2021.
4.2. ReLEx SMILE
ReLEx SMILE surgeries were performed using the technology described by W. Sekundo [
50]. The thickness of the upper tissue arcade (cap) was 120 µm, with an intended diameter of 7.5 mm, whereas the average diameter of the refractive lenticule varied from 6.0 to 7.0 mm. An VisuMaxTM FS laser system (Carl Zeiss Meditec, Jena, Germany) was used to perform a 90-degree lateral circumferential incision of 2.5 mm at the superior temporal position and a cap sidecut angle of 35–40 degrees.
Following the cutting procedure, the refractive lenticule was dissected, separated through the side-cut, and manually removed. A total of 60 stromal lenticules of 50–175 μm in thickness were obtained from 17 male and 13 female patients whose ages ranged from 18 to 37 years.
4.3. Corneal Stromal Cell Isolation and Expansion
Every two lenticules from each patient were cut with scissors and treated with 62.5 U/mL collagenase I (Sigma-Aldrich, Saint Louis, MO, USA) supplemented with 2% FCS (HyClone, FCS; Hyclone, Logan, UT, USA) at 37 °C for 18–20 h [
17]. Then the tissue debris was removed by filtration through a 100 µm cell filter (BD Falcon, Brea, CA, USA). The cells were washed twice in a phosphate buffer solution (PBS), centrifuged at 402×
g for 10 min and seeded onto a 24-well plate (TPP, Trasadingen, Switzerland). The keratocyte culture was obtained from these cells with cultivation in KGM containing advanced DMEM/F12, 10 ng/mL human basic fibroblast growth factor (bFGF; Sigma-Aldrich, Saint Louis, MO, USA), 1 mM L-ascorbate 2-phosphate (Sigma-Aldrich, Saint Louis, MO, USA), and ITS (insulin–transferrin–selenium solution, X100; Gibco, Carlsbad, CA, USA), 40 µg/mL gentamycin (Dalkhimpharm, Khabarovsk, Russia), 1% Gluta-MAX (Gibco, Carlsbad, CA, USA) at 37 °C in 5% CO
2 conditions, with the culture medium replaced every 3–4 days. To obtain CFs, the extracted cells were cultured in DMEM/F12 supplemented with 10% fetal calf serum (FCS; Hyclone, Logan, UT, USA), 1% Gluta-MAX, 5 mM HEPES buffer (Sigma-Aldrich, Saint Louis, MO, USA), and 40 µg/mL gentamycin at 37 °C in 5% CO
2 conditions until reaching a confluent monolayer, with the culture medium refreshed every 3–4 days. Once the primary cultures reached 80–90% confluence, the adherent cells were detached using a 0.25% trypsin/0.02% EDTA solution (Biolot, Saint Petersburg, Russia). CF passages 3 through 6 were used for further studies.
4.4. Corneal Fibroblast Reversion into Keratocytes
hCSCs were cultured in KGM during 21 days at 37 °C in 5% CO2 conditions, with the medium refreshed every 3–4 days. At the end of the differentiation, the cells were characterized and used in experiments.
4.5. Transmission Electron Microscopy
hCSCs were cultured in culture flasks, 25 cm2 (TPP, Trasadingen, Switzerland) at ~90% confluence, and then adhesive cells were detached from the plastic using a solution of 0.25% trypsin/0.02% EDTA (Biolot, Saint Petersburg, Russia). The cells were precipitated by centrifugation at 402× g for 10 min. Then the cell pellet was fixed with a 4% paraformaldehyde in the Hanks medium and 1% OsO4 solution (Sigma-Aldrich, Saint Louis, MO, USA) with phosphate buffer (pH 7.4) for 1 h, dehydrated in ethanol in ascending concentrations, and embedded in epon (Serva). Semithin 1 μ sections were prepared using the Leica EM UC7 microtome, stained with toluidine blue, and orientated for electron microscopy. The semithin sections with the thickness of 70–100 nm were contrasted with a saturated water solution of uranyl acetate and lead citrate, and analyzed using the JEM 1400 electron microscope (Jeol) (Multiple-access Center for Microscopy of Biological Subjects, Institute of Cytology and Genetics, Novosibirsk, Russia).
Morphometric measurements: hCSCs (50 cells per group) were analyzed at ×15,000 magnification using the ImageJ 1.48 v software (National Institutes of Health, Bethesda, MD, USA). The volume density of mitochondria, rough endoplasmic reticulum, Golgi complex, and lysosomes were counted.
Statistical analysis: the mean (M) and standard deviation (SD) were calculated using the Microsoft Excel 2016 software (Microsoft, Redmond, WA, USA). The significance of differences between the studied parameters was determined employing the Statistica 6.0 software (StatSoft, Tulsa, OK, USA), using the Mann–Whitney U-test at a confidence level of 95% (p < 0.05).
4.6. Phenotyping of Corneal Stromal Cells
The phenotype of obtained hCSCs was investigated in a CytoFLEX S flow cytometer (Beckman Coulter, Brea, CA, USA) using monoclonal antibodies to CD29 (100 µg/mL, cat. no. 303004), CD44 (50 µg/mL, cat. no. 338808), CD49a (200 µg/mL, cat. no. 328303), CD54 (100 µg/mL, cat. no. 353106) (all antibodies: Biolegend, San Diego, CA, USA), CD34 (25 µg/mL, cat. no. 345801), CD45 (6 mg/mL, cat. no. 332784), CD184 (20 µL per test, cat. no. 555976), HLA DR (1:20, cat. no. 560652), CD73 (6.3 µg/mL, cat. no. 550257), CD90 (0.5 mg/mL, cat. no. 561969), and CD105 (100 µg/mL, cat. no. 562408) (all antibodies: BD Biosciences Pharmingen, San Diego, CA, USA), and monoclonal antibodies to keratocan (1:50, cat no. orb7921; Biorbyt, Cambridge, UK), lumican (1:50, cat no. orb124743; Biorbyt, Cambridge, UK), and aldehyde dehydrogenase 1 family member A1 (ALDH1A1) (1:50, cat no. 32005-05161, AssayPro, St. Charles, MO, USA), following the instructions provided by the manufacturer. Briefly, the culture medium was removed, the culture flasks were washed once with PBS, and the adherent cells were detached using a 0.25% trypsin/0.02% EDTA solution (Biolot, Saint Petersburg, Russia). Then the cells were harvested, washed, and the cell number adjusted to a concentration of 1 × 106 cells/mL in ice-cold FACS Buffer (PBS, 1% BSA, 0.1% NaN3 sodium azide). The cells were stained in BD Falcon tubes in 100 μL cell suspension and 0.1–10 μg/mL antibody added to each tube and incubated for 30 min at 4 °C in the dark. Then, the cells were centrifuged 3× g times in 1 mL of BSA-free ice-cold FACS buffer at 402× g for 5 min. The pellet was suspended in 400 µL of FACS buffer. To analyze keratocan, lumican, and ALDH1A1 expression, the cells were harvested, washed with PBS, fixed and permeabilized using 0.2% Tween20 (Merck, Millipore, Sigma-Aldrich, Supelco, Germany), following the instructions provided by the manufacturer. Then the cells were stained with rabbit anti-human keratocan, rabbit anti-human lumican or rabbit anti-human ALDH1A1 antibody (1:50), and washed three times with PBS. The stained cells were analyzed using the flow cytometer, a minimum of 10,000 events per experiment.
4.7. Immunocytochemistry
Cells of 3–6th passage were attached to L-polylysine-coated glass slides, fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 (Bio-Rad, Hercules, CA, USA) for 20 min at room temperature, and then blocked with 1% bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 1 h, and incubated with mouse anti-CD90 (1:100, cat. no. ab134358; Abcam, Cambridge, UK), rabbit anti-alpha smooth muscle actin (1:100, cat. no. A17910; ABclonal, Wuhan, China), mouse anti-fibronectin (1:100, cat. no. ab6328; Abcam, Cambridge, UK) monoclonal antibody conjugated with fluorochrome for 12 h at 4 °C. Then, the cells were incubated for 40 min at room temperature with secondary antibodies (goat anti-mouse IgG conjugated with Alexa Fluor 488, 1:400, cat. no. A11029; Thermo Fisher Scientific, Waltham, MA, USA and goat anti-rabbit IgG conjugated with Alexa Fluor 488, 1:400, cat. no. ab150077; Abcam, Boston, MA, USA) and washed. The cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI, Abcam, Cambridge, UK). The actin–cytoskeleton of the cells was stained with phalloidin coupled with Alexa Flour 488 (1:200, cat. no. A12379, Thermo Fisher Scientific, Waltham, MA, USA) for 60 minutes, as per the manufacturer’s instructions. The cells were photographed using an Axio Observer microscope (Carl Zeiss, Oberkochen, Germany).
4.8. Sphere Formation of Reversed Fibroblasts
In the case of the fibroblasts being reversed into the keratocytes that spontaneously formed into spheres, the last were characterized (their diameter, area, and number) using an Axio Observer microscope (Carl Zeiss, Oberkochen, Germany).
4.9. Real-Time Cell Proliferation Monitoring
An xCELLigence impedance-based real-time cell analyzer (RTCA) (Roche, Applies Science, Indianapolis, IN, USA) was used to assess CF and rCF proliferation. The cells were seeded at densities of 1 × 104 cells/well into an E-plate 16 (ACEA Biosciences, San Diego, CA, USA) with 200 μL media containing 2% FCS or 10% FCS, and cultivated at 37 °C in a humidified 5% CO2 incubator. The impedance value of each well was monitored automatically by the RTCA every hour for 120 h. The electrical impedance was measured by the RTCA and quantified by its software v. 1.2.1 as a dimensionless parameter, cell index (CI), which allowed for the analysis of cell adhesion, spreading, proliferation, cell viability/death, and detachment in real time.
4.10. Real-Time Cell Migration Monitoring
Real-time cell migration was measured using the xCELLigence RTCA DP instrument equipped with a CIM-plate 16. The plate is a 16-well system, where in each well, the upper and lower chambers are separated by an 8 μm microporous membrane. CFs and rCFs were seeded at densities of 1 × 104 cells/well into the upper chamber in a serum-free medium. DMEM/F12 and KGM supplemented with 2% and 10% FCS were placed in the bottom chambers as a chemoattractant. The migration was measured as the relative rate of change (CI) across the microelectronics integrated into the bottom side of the membrane. The impedance value of each well was monitored automatically by the instrument every hour for 72 h. The result was quantified using the RTCA software v. 1.2.1.
4.11. Obtaining Conditioned Media
After the culture reached 90–100% confluence, the medium was removed and the culture flasks were washed thoroughly with PBS, and a fresh growth medium without FCS was added. The cells were cultured for 24 h and then the culture supernatants were collected and stored at −20 °C.
4.12. ELISA
Commercially available ELISA kits were used to determine the human insulin growth factor-1 (IGF-1), human free brain-derived neurotrophic factor (BDNF) (all kits: R&D Systems, Minnesota, MN, USA), human stromal-derived factor-1a (SDF-1a; Thermo Scientific, Waltham, MA, USA), human vimentin, total collagen, human fibronectin (all kits: Abcam, Boston, MA, USA), human soluble intercellular adhesion molecule-1 (sICAM-1; Affymetrix eBioscience, Santa Clara, CA, USA), vascular endothelial growth factor (VEGF), erythropoietin (EPO), and tumor necrosis factor-alpha (TNF-α) (all kits: Vector-BEST, Novosibirsk, Russia), produced by the CFs and rCFs. The kits were applied as per the manufacturer’s recommendations.
4.13. Statistical Analysis
Statistical analysis was performed using Statistica 10.0 (Stat Soft Inc., Tulsa, OK, USA). The Shapiro–Wilk test was used to confirm the data distribution normality. The obtained data were presented as the mean ± SD (standard deviation) and analyzed by a one-way analysis of variance (ANOVA), followed by Bonferroni’s multiple comparison post hoc test. Statistical significance between the groups was established for p < 0.05.